Rebamipide protects against activation of neutrophils byHelicobacter pylori-Reference-Cited by-同舟云学术

Rebamipide protects against activation of neutrophils byHelicobacter pylori

Published:1996-06 Issue:6 Volume:41 Page:1139-1144
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Digest Dis Sci

Author:

Yoshida Norimasa,Yoshikawa Toshikazu,Iinuma Shoji,Arai Masahiro,Takenaka Sinya,Sakamoto Kyoko,Miyajima Takashi,Nakamura Yasunari,Yagi Nobuaki,Naito Yuji,Mukai Fumie,Kondo Motoharu

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/BF02088229.pdf

Reference23 articles.

1. Graham DY: Pathogenic mechanisms leading toHelicobacter pylori-induced inflammation. Eur J Gastroenterol Hepatol 4:S9-S16, 1992

2. Blaser MJ: Hypothesis on the pathogenesis and natural history ofHelicobacter pylori-induced inflammation. Gastroenterology 102:720–727, 1992

3. Yoshida N, Granger DN, Evans Jr. DJ, Evans DG, Graham DY, Anderson DC, Wolf RE, Kvietys PR: Mechanisms involved inHelicobacter pylori-induced inflammation. Gastroenterology 105:1431–1440, 1993

4. Iinuma S, Yoshida N, Takenaka K, Sakamoto T, Miyajima T, Arai M, Nakamura Y, Takemura T, Yoshikawa T, Kondo M: Neutrophil activation induced byH. pylori extract. Gastroenterology 108:A120, 1995

5. Kozol R, Domanowski A, Jaszewski R, Czanko R, McCurdy B, Prasad M, Fromm B, Calzada R: Neutrophil chemotaxis in gastric mucosa: A signal-to-response comparison. Dig Dis Sci 36:1277–1280, 1991

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes;PLOS ONE;2022-12-27

2. Gastroprotectant Rebamipide: review of action mechanisms and clinical applications;Glavvrač (Chief Medical Officer);2022-03-20

3. Evaluation of oral rebamipide as a potential therapy for Sjögren syndrome-related dry eye and mouth;Indian Journal of Rheumatology;2021

4. Modern opportunities for treatment and prevention of NSAID-induced enteropathies;Meditsinskiy sovet = Medical Council;2020-05-21

5. Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function;Scientific Reports;2020-02-03